Skip to main content
. 2022 Jul 21;14(14):2986. doi: 10.3390/nu14142986

Table 4.

The effect of the study outcomes on glycemic outcomes.

Peanut Group Control Group p-Values
Time (Months) 0
(n = 57)
3
(n = 46)
6
(n = 43)
0
(n= 44)
3
(n = 35)
6
(n = 32)
Diet Visit Diet x Visit
Fasting glucose, mmol/L 5.12 ± 0.04 1 5.01 ± 0.05 4.99 ± 0.05 5.13 ± 0.05 4.96 ± 0.05 4 4.90 ± 0.06 5 0.37 <0.001 0.46
Fasting insulin, u/mL 10.89 ± 0.52 8.95 ± 0.58 8.14 ± 0.59 3 11.42 ± 0.59 8.15 ± 0.67 7.33 ± 0.70 0.50 <0.001 0.41
2-h glucose, mmol/L 5.84 ± 0.17 1 5.93 ± 0.19 2 6.06 ± 0.19 5.89 ± 0.19 6.30 ± 0.21 4 6.41 ± 0.22 5 0.18 0.09 0.58
HbA1c, % 5.61 ± 0.02 5.50 ± 0.02 5.48 ± 0.02 5.61 ± 0.02 2 5.55 ± 0.02 5.49 ± 0.02 0.21 <0.001 0.32
HOMA-IR 2.49 ± 0.12 1 2.09 ± 0.14 1.88 ± 0.14 2.66 ± 0.14 1.83 ± 0.16 4 1.60 ± 0.17 5 0.35 <0.001 0.17

Data presented as least squares means ± standard error of mean. Data were analyzed by using linear mixed models (PROC MIXED; SAS Version 9.4). The effect of diet on each outcome was examined with visit modeled as a repeated effect and the baseline value included as a covariate; 1 n = 56; 2 n = 45; 3 n = 44; 4 n = 34; 5 n = 31. HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment for insulin resistance.